← Back to Search

Stigma Reduction Strategies for HIV Prevention Engagement

N/A
Waitlist Available
Research Sponsored by Bryan Kutner
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
have had anal intercourse with a man in the past year or intend to in the next year
report being assigned male at birth and identifying currently as male
Timeline
Screening 3 weeks
Treatment Varies
Follow Up (1) baseline, pre-intervention, (2) post-intervention 1 week after completion of mhealth component, (3) post-intervention 1 week after completion of the in-person workshop, (4) post-intervention 3 months after completion of all implementation strategies
Awards & highlights

Study Summary

This trial is to find out how to make healthcare workers more comfortable with anal sex so that gay and bisexual men will be more likely to get HIV-related services.

Who is the study for?
This trial is for males assigned at birth, currently identifying as male, living in the U.S., who have had or plan to have anal intercourse with a man within a year. Participants must be 18+, able to read and communicate in English, and interested in HIV-related services.Check my eligibility
What is being tested?
The study is testing strategies to reduce sexual stigma by healthcare workers towards gay and bisexual men. The goal is to improve these men's engagement in HIV prevention services through developing and piloting an intervention for health professionals.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not expected. However, participants may experience emotional or psychological responses during the process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had or plan to have anal intercourse with a man within a year.
Select...
I was assigned male at birth and identify as male.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention, 1 week after completion of the mhealth component
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention, 1 week after completion of the mhealth component for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability, appropriateness, and feasibility of the coaching calls and optional email listserv as assessed by the AFAS
Acceptability, appropriateness, and feasibility of the in-person skills development workshop as assessed by the AFAS
Acceptability, appropriateness, and feasibility of the mHealth component as assessed by the AFAS
+4 more
Secondary outcome measures
Changes to comfort discussing anal health and sexuality as assessed by 6 study-specific items
Changes to determinants of implementation behavior as assessed by the DIBQ
Changes to knowledge about anal health and sexuality as assessed by the iASK
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pre-post designExperimental Treatment1 Intervention
The pilot intervention will be evaluated using a pre-post design.

Find a Location

Who is running the clinical trial?

Bryan KutnerLead Sponsor
Albert Einstein College of MedicineOTHER
287 Previous Clinical Trials
11,857,020 Total Patients Enrolled
Columbia UniversityOTHER
1,439 Previous Clinical Trials
2,448,631 Total Patients Enrolled

Media Library

Pre-post design Clinical Trial Eligibility Overview. Trial Name: NCT04779736 — N/A
HIV/AIDS Research Study Groups: Pre-post design
HIV/AIDS Clinical Trial 2023: Pre-post design Highlights & Side Effects. Trial Name: NCT04779736 — N/A
Pre-post design 2023 Treatment Timeline for Medical Study. Trial Name: NCT04779736 — N/A
~10 spots leftby Aug 2024